BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B. 2011

Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Department of Pharmaceutical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, 4209 State Route 44, Rootstown, OH 44272, USA.

The neuroprotective activity of pioglitazone and rosiglitazone in the MPTP parkinsonian mouse prompted us to evaluate a set of thiazolidinedione (TZD) type compounds for monoamine oxidase A and B inhibition activity. These compounds were able to inhibit MAO-B over several log units of magnitude (82 nM to 600 μM). Initial structure-activity relationship studies identified key areas to modify the aromatic substituted TZD compounds. Primarily, substitutions on the aromatic group and the TZD nitrogen were key areas where activity was enhanced within this group of compounds.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Enhancing monoamine oxidase B inhibitory activity via chiral fluorination: Structure-activity relationship, biological evaluation, and molecular docking study.
January 2022, European journal of medicinal chemistry,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship.
May 1995, Biochemistry and molecular biology international,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors.
January 2018, Frontiers in chemistry,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Structure activity studies of the substrate binding site in monoamine oxidase B.
January 1995, Biochimie,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Structure-activity relationship of antioxidant prenylated (iso)flavonoid-type compounds: quantum chemistry and molecular docking studies.
January 2022, Journal of biomolecular structure & dynamics,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies.
November 2022, European journal of medicinal chemistry,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
STRUCTURE AND ACTIVITY RELATIONSHIP OF MONOAMINE OXIDASE INHIBITORS, PHENYLACETYLHYDRAZIDE DERIVATIVES.
August 1963, Japanese journal of pharmacology,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Quantitative structure-activity studies on monoamine oxidase inhibitors.
May 1976, Journal of medicinal chemistry,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Molecular docking of inhibitors into monoamine oxidase B.
August 2007, Biochemical and biophysical research communications,
Richard T Carroll, and Dean E Dluzen, and Hilary Stinnett, and Prabha S Awale, and Max O Funk, and Werner J Geldenhuys
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
November 2008, Journal of medicinal chemistry,
Copied contents to your clipboard!